Roche's arthritis drug tocilizumab cuts the risk of death among patients hospitalized with severe COVID-19, also shortening the time to recovery and reducing the need for mechanical ventilation, a large clinical trial suggests.
Roche arthritis drug cuts deaths in hospitalized COVID-19 patients, study suggests
Post a Comment